Nature`s Sunshine Products (NATR) has a profit margin of 3.05%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
Nature`s Sunshine Products posts a profit margin of 3.05% as of September 2026. That compares with 4.36% in the prior-year period — down 30.0% year over year. That is below the Healthcare sector average of 17.63%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Nature`s Sunshine Products's profit margin was 4.36%. The latest reading is 3.05% — a 30.0% year-over-year decrease (period ending September 2026). Use the history and growth charts on this page for a longer lookback.
For Healthcare stocks, a profit margin near 17.63% is typical. Nature`s Sunshine Products's 3.05% is lower that level. That is roughly 82.7% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Nature`s Sunshine Products's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 3.05% as of September 2026; use YoY and peer views to separate noise from signal.
Context for NATR's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 17.63%), and (3) consistency with growth and profitability. This page covers the first two; Nature`s Sunshine Products's other metric pages and overview cover the third.